STOCK TITAN
  1. Home
  2. Sec-filings
  3. STE
  4. [Form 4] STERIS plc Insider Trading Activity

STERIS (NYSE: STE) CEO granted shares and options; tax shares withheld

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STERIS plc President and CEO Daniel A. Carestio reported equity compensation and related tax withholding transactions. He received 23,736 ordinary shares as a grant and 82,740 employee stock options with an exercise price of $230.74 per share, expiring in 2036.

On the same date, 2,369 restricted shares vested, and 995 of those shares were withheld at $209.76 per share to cover employment and tax obligations, rather than sold in the market. After these transactions, he directly owned 73,578 ordinary shares, of which 50,113 were restricted as of June 2, 2026, subject to a multi-year vesting schedule.

Positive

  • None.

Negative

  • None.
Insider Carestio Daniel A
Role President and CEO
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) 82,740 $0.00 --
Grant/Award Ordinary Shares 23,736 $0.00 --
Tax Withholding Ordinary Shares 995 $209.76 $209K
Holdings After Transaction: Employee Stock Option (right to buy) — 82,740 shares (Direct, null); Ordinary Shares — 73,578 shares (Direct, null)
Footnotes (1)
  1. As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. 995 shares were withheld from the 2,369 restricted shares that vested on June 2, 2026. These 995 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. This option becomes exercisable as follows: 20,685 on June 2, 2027, 20,685 on June 2, 2028, 20,685 on June 4, 2029 and 20,685 on June 3, 2030.
Shares granted 23,736 ordinary shares Grant to CEO on June 2, 2026
Options granted 82,740 options at $230.74/share Employee stock options expiring June 2, 2036
Tax-withheld shares 995 shares at $209.76/share Shares withheld from vested restricted stock for taxes
Post-transaction holdings 73,578 ordinary shares CEO direct ownership after transactions
Restricted shares outstanding 50,113 ordinary shares Restricted as of June 2, 2026 with staged lapse
Vested restricted shares 2,369 ordinary shares Restricted shares that vested on June 2, 2026
restricted financial
"As of June 2, 2026, 50,113 of these ordinary shares are restricted."
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) with underlying 82,740 ordinary shares."
taxes required to be withheld financial
"These 995 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws."
NYSE closing market price financial
"These vested shares were valued at the NYSE closing market price on June 2, 2026."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carestio Daniel A
(Last)(First)(Middle)
70 SIR JOHN ROGERSON'S QUAY
(Street)
DUBLIN 2D02 R296
(City)(State)(Zip)
IRELAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares06/02/2026A23,736A$073,578(1)D
Ordinary Shares06/02/2026F995(2)D$209.7672,583(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$230.7406/02/2026A82,740 (3)06/02/2036Ordinary Shares82,740$082,740D
Explanation of Responses:
1. As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029.
2. 995 shares were withheld from the 2,369 restricted shares that vested on June 2, 2026. These 995 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
3. This option becomes exercisable as follows: 20,685 on June 2, 2027, 20,685 on June 2, 2028, 20,685 on June 4, 2029 and 20,685 on June 3, 2030.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did STERIS (STE) CEO Daniel Carestio receive?

Daniel Carestio received a grant of 23,736 STERIS ordinary shares and 82,740 employee stock options at an exercise price of $230.74 per share. These awards represent equity-based compensation that vests over multiple future dates according to the company’s disclosed schedule.

Were any STERIS (STE) shares sold by the CEO in this Form 4?

No open-market sale occurred; 995 shares were withheld from 2,369 vested restricted shares to satisfy tax obligations. These shares were valued at the NYSE closing market price on June 2, 2026, and reflect tax withholding rather than a discretionary sale.

How many STERIS (STE) shares does the CEO hold after these transactions?

After these transactions, Daniel Carestio directly held 73,578 STERIS ordinary shares. Of this total, 50,113 shares were restricted as of June 2, 2026, and are scheduled to lapse in tranches between 2026 and 2029 under the company’s vesting timetable.

What are the key terms of the new STERIS (STE) stock options granted to the CEO?

The CEO received 82,740 employee stock options with an exercise price of $230.74 per share and an expiration date of June 2, 2036. These options become exercisable in four equal installments between 2027 and 2030, according to the vesting schedule disclosed.

How many STERIS (STE) restricted shares vested for the CEO on June 2, 2026?

On June 2, 2026, 2,369 restricted STERIS ordinary shares vested for Daniel Carestio. From this vesting, 995 shares were withheld to cover required taxes, while the remaining vested shares increased his directly held ordinary share position at that time.